<VariationArchive VariationID="3244463" VariationName="NC_000023.10:g.(?_77041448)_(77041487_?)del" VariationType="Deletion" Accession="VCV003244463" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3403395" VariationID="3244463">
      <GeneList>
        <Gene Symbol="ATRX" FullName="ATRX chromatin remodeler" GeneID="546" HGNC_ID="HGNC:886" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77504880" stop="77786216" display_start="77504880" display_stop="77786216" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76760355" stop="77041718" display_start="76760355" display_stop="77041718" Strand="-" />
          </Location>
          <OMIM>300032</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_77041448)_(77041487_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="77041448" innerStop="77041487" display_start="77041448" display_stop="77041487" variantLength="40" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_77041448)_(77041487_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_77041448)_(77041487_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_77041448)_(77041487_?)del AND Alpha thalassemia-X-linked intellectual disability syndrome" Accession="RCV004580049" Version="1">
        <ClassifiedConditionList TraitSetID="3190">
          <ClassifiedCondition DB="MedGen" ID="C1845055">Alpha thalassemia-X-linked intellectual disability syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11449489</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15591283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18409179</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23681356</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3190" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="281" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked alpha-thalassemia-mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha thalassemia mental retardation syndrome, nondeletion type, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR, nondeletion type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">XLMR hypotonic face syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-Thalassemia X-Linked Intellectual Disability  Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alpha thalassemia-X-linked intellectual disability syndrome</ElementValue>
                <XRef ID="MONDO:0010519" DB="MONDO" />
                <XRef ID="715342005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR-X syndrome</ElementValue>
                <XRef ID="ATR-X+Syndrome/647" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATRX</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.</Attribute>
                <XRef ID="NBK1449" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5864" />
                <XRef ID="5864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301622</ID>
                <ID Source="BookShelf">NBK1449</ID>
              </Citation>
              <XRef ID="847" DB="Orphanet" />
              <XRef ID="C1845055" DB="MedGen" />
              <XRef ID="MONDO:0010519" DB="MONDO" />
              <XRef Type="MIM" ID="301040" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9834975" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_77041448)_(77041487_?)del|MedGen:C1845055" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005062558" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15591283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18409179</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23681356</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11449489</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1 of the ATRX gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATRX are known to be pathogenic (PMID: 15591283, 18409179, 23681356). A similar copy number variant has been observed in individual(s) with ATRX-related conditions (PMID: 11449489). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_77041448)_(77041487_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845055" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9834975" TraitType="Disease" MappingType="XRef" MappingValue="C1845055" MappingRef="MedGen">
        <MedGen CUI="C1845055" Name="Alpha thalassemia-X-linked intellectual disability syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

